levalbuterol has been researched along with ambroxol in 1 studies
Studies (levalbuterol) | Trials (levalbuterol) | Recent Studies (post-2010) (levalbuterol) | Studies (ambroxol) | Trials (ambroxol) | Recent Studies (post-2010) (ambroxol) |
---|---|---|---|---|---|
24 | 5 | 19 | 714 | 130 | 225 |
Protein | Taxonomy | levalbuterol (IC50) | ambroxol (IC50) |
---|---|---|---|
Lysosomal acid glucosylceramidase | Homo sapiens (human) | 4.1 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.5574 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 3.391 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Esaulova, NA; Leshchenko, IV; Viktorova, IA; Zaitsev, AA | 1 |
1 trial(s) available for levalbuterol and ambroxol
Article | Year |
---|---|
[Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronch
Topics: Acute Disease; Adult; Albuterol; Ambroxol; Bromhexine; Bronchitis; Cough; Drug Combinations; Expectorants; Guaifenesin; Humans; Levalbuterol; Treatment Outcome | 2023 |